Luciferase Reporter Cell Line - T24

T24 cells are a human bladder transitional cell carcinoma (urothelial carcinoma)–derived cell line widely used as an in vitro model for studying bladder cancer biology and urinary tract tumor progression. These cells are characterized by epithelial morphology, strong proliferative ability, and genetic alterations associated with high-grade urothelial carcinoma. T24 cells exhibit dysregulated signaling pathways involved in cell cycle control, migration, invasion, and epithelial–mesenchymal transition (EMT), making them suitable for investigating tumor aggressiveness and metastatic potential. The Luciferase Reporter Cell Line – T24 is generated by stable integration of a luciferase reporter construct driven by pathway-responsive elements or transcription factor–specific promoters into the parental T24 background, enabling real-time, sensitive, and quantitative monitoring of transcriptional and signaling activities while maintaining the intrinsic biological properties of the original cell line.

The Luciferase Reporter Cell Line – T24 is widely applied in bladder cancer research, oncogenic signaling studies, and anti-cancer drug screening. It is particularly useful for evaluating key pathways implicated in urothelial carcinoma progression, including PI3K/AKT/mTOR, MAPK/ERK, NF-κB, and TGF-β/SMAD signaling, as well as mechanisms related to EMT and cell motility. The luciferase reporter system provides a robust and highly sensitive readout for detecting pathway modulation following treatment with small molecules, biologics, or genetic perturbations. This model is frequently used in high-throughput screening of anti-tumor and anti-metastatic compounds, as well as in mechanistic studies of tumor invasion and therapeutic resistance. Its stability, reproducibility, and quantitative output make it a valuable tool for both basic research and preclinical evaluation in bladder cancer drug development.